- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Diabetes
The Endocrinology Network® Diabetes clinical resource center offers readers the very latest news and information related to diabetes management. Including content related to type 1 diabetes, type 2 diabetes, and gestational diabetes, the diabetes clinical resource center hosts information on FDA approvals, the latest studies, and practice updates for clinicians practicing in the field of endocrinology.
Patients with Diabetes Remain at Increased Fracture Risk, Despite Declines in Overall Population
October 07, 2021
An analysis of more than 1.2 million patients who experienced a fracture from 1997-2017 provides insight into contemporary trends in fracture incidence rates based on presence of diabetes.
ATA Study Details Risk Factors, Comorbidities Associated with Severe Thyroid Eye Disease
October 07, 2021
An analysis of more than 650 thyroid eye disease patients is providing clinicians with insight into the most common comorbidities and risk factors associated with increased disease severity in patients with TED.
COVID-19 Pandemic Has Made Diabetes Management More Difficult for US Patients
October 04, 2021
An analysis of survey data from nearly 800 patients with diabetes provides insight into the effects of the pandemic on diabetes management, including increased difficulty in affording diabetes medications and consulting with their diabetes care providers.
ADA and EASD Publish Guidance on Diagnosis, Management of Type 1 Diabetes
October 01, 2021
Published on September 30, the consensus report provides perspective on diagnosis and management of type 1 diabetes, including a diagnosis algorithm and insight on CGM specific to type 1 diabetes, which the writing group noted is lacking from previous guidance.
Increased Insulin Resistance Could Signal Stroke Risk in Patients with Diabetes
September 28, 2021
A study from EASD 2021 suggests increased insulin resistance could help predict risk of incident stroke events among adult patients with type 2 diabetes, with results indicating lowest levels of insulin resistance were at a 40% lower risk of stroke compared to those with the highest levels.
Major Weight Loss Could Return Cardiovascular Risk to Normal Levels in Patients with Obesity
September 28, 2021
An analysis of NHANES data presented at EASD 2021 details the effects of returning to a healthy weight among patients with obesity compared to those currently with obesity and those who always maintained a healthy weight.
Use of Alendronate Could Lower Odds of Developing Type 2 Diabetes
September 28, 2021
An analysis of patient data from a national registry in Denmark indicates use of alendronate was associated with reductions in odds of developing type 2 diabetes, with this reduction becoming greater with longer use of the osteoporosis medication.
Cardiovascular Care for Women with Diabetes Lagging Behind Care for Men
September 27, 2021
A posthoc analysis of the REWIND trial is providing insight into the overall standard of care seen with women with diabetes and increased cardiovascular risk compared to their male counterparts with diabetes and increased cardiovascular risk.
Endocrine Month in Review: September 2021
September 25, 2021
September's endocrine month in review features news related to diabetes, polycystic ovary syndrome, warnings from the FDA and FTC, and a column from Dr. Paul Thompson.
Treating Polycystic Ovary Syndrome Costs $8 Billion in US Annually
September 22, 2021
A meta-analysis builds upon previous research and provides new insight into the total costs of diagnosis and treating PCOS as well as the costs of treating PCOS-related comorbidities.